β-Arrestin-Mediated Signaling Improves the Efficacy of Therapeutics
β-Arrestins (β-arrestin-1 and β-arrestin-2) were first identified as proteins that have the ability to desensitize G protein-coupled receptors (GPCRs). However, it has recently been found that β-arrestins can activate signaling pathways independent of G protein activation. The diversity of these sig...
Saved in:
Main Authors: | Islam A.A.E.-H. Ibrahim (Author), Hitoshi Kurose (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling
by: Supachoke Mangmool, et al.
Published: (2018) -
Ezrin, Radixin, and Moesin Phosphorylation in NIH3T3 Cells Revealed Angiotensin II Type 1 Receptor Cell-Type-Dependent Biased Signaling
by: Islam A.A.E-H. Ibrahim, et al.
Published: (2013) -
Structural features of arrestin-mediated GPCR signaling
by: Wenqin Xie, et al.
Published: (2024) -
β-Arrestin Based Receptor Signaling Paradigms: Potential Therapeutic Targets for Complex Age-Related Disorders
by: Jaana van Gastel, et al.
Published: (2018) -
New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis
by: Anna Bagnato, et al.
Published: (2019)